Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 4, 1999, Pages 290-294

  Perri, F ^a  

^a Divisions di Gastroenterologia Casa Sollievo Della Sofferenza   (Italy)

Author keywords

CagA; Gastritis; Helicobacter pylori; Tumour necrosis factor ; Urea breath test

Indexed keywords

BACTERIUM ANTIBODY; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA; UREA;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BREATH ANALYSIS; DUODENUM ULCER; ENDOSCOPY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; STOMACH BIOPSY;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOPSY; BREATH TESTS; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NEUTROPHILS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033001107     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Noach LA, Bosma NB, Jansen J, Hoek FJ, Van Deventer SJH, Tytgat GNJ. Mucosal tumour necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994;29:425-9.
2. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor-alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-7.
3. Fan XJ, Chua A, O'Connell MA, Kelleher D, Keeling PW. Interferon-gamma and tumour necrosis factor production in patients with Helicobacter pylori infection. Ir J Med Sei 1993;162:408-11.
4. Denizot Y, Sobhani I, Rambaud JC, Lewin M, Thomas Y, Benveniste J. Pafacether synthesis by Helicobacter pylori. Gut 1990;31:1242-5.
5. Crabtree JE, PeichI P, Wyatt JJ, Stachl U, Lindley IJ. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol 1993;37:65-70.
6. Censini S, Lane C, Xiang Z, Crabtree JE, Ghiara P, Borodovski M, et al. Cag, a pathogenicity island of Helicobacter pylori encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sei USA 1996;93:14648-53.
7. Figura N. Progress in defining the inflammatory cascade. Eur J Gastroenterol Hepatol 1995;7:296-302.
8. Gasbarrini A, Franceschi F, Gasbarrini G, Pola P. Extraintestinal pathology associated with Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1997;9:231-3.
9. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-9.
10. Gasbarrini A, Serricchio M, Tondi P, Gasbarrini G, Pola P. Association with Helicobacter pylori infection with primary Raynaud phenomenon. Lancet 1996;348:966-7.
11. Dufour C, Brisigotti M, Fabretti G, Luxardo P, Mori PG, Barabino A. Helicobacter pylori gastric infection and sideropenic refractory anaemia. J Pediatr Gastr Nutr 1993;17:225-7.
12. Patel P, Mendall MA, Khulusi S, Northfield TC, Strachan DP. Helicobacter pylori infection in childhood: risk factors and effect on growth. Br Med J 1994;309:1119-23.
13. Perri F, Pastore M, Leandro G, Clemente R, Ghoos Y, Peelers M, et al. Helicobacter pylori infection and growth delay in older children. Arch Dis Child 1997;77:46-9.
14. Burnett RA, Brown IL, Findlay J. Cresyl fast violet staining method for Campylobacter like organisms. J Clin Pathol 1987;40:353-9.
15. Price AB. The Sydney system;histological division. J Gastroenterol Hepatol 1991 ;6:209-22.
16. El-Zimaity HMT, Graham DY, Al-Assi MT, Malaty H, Karttunen TJ, Graham DP, et al. Interobserver variation in the histopathological assessment of H. pylori gastritis. Hum Pathol 1996;27:35-41.
17. Mook WG, Grootes PM. The measuring procedure and corrections for the high precision mass-spectrometric analysis of isotopic abundance ratios, especially referring to carbon, oxygen, and nitrogen, Int J Mass Spectr Ion Phys 1973;12:273-98.
18. Perri F, Clémente R, Pastore M, Quitadamo M, Festa V, Bisceglia M, et al. The 13C-urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Lab Clin Invest 1998:58:19-28.
19. Blaser MJ. Heterogeneity of Helicobacter pylori. Eur J Gastroenterol Hepatol 1997;9 (Suppl.1):S3-7.
20. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996;110:1744-52.
21. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997;41:442-51.
22. Atherton JC, Tham KT, Peek RM Jr, Cover TL, Blaser MJ. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis 1996; 174:552-6.
23. Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, et al. Cytotoxin production by Campylobacter strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989;27:225-6.
24. Crabtree JE, Taylor JD, Wjatt JI, Heatley RV, Shallcross TM, Tompkins DS, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
25. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
26. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophie gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
27. Go MF, Graham DY. The cagA gene is present in the majority of Helicobacter pylori strains independent of whether the individual has duodenal ulcer or asymptomatic gastritis. Helicobacter 1996;1:107-11.
28. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in developing countries. Am J Gastroenterol 1996;91:1785-8.
29. Van Doom LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, De Boer W, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998:115:58-66.
30. 0 Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997:113:1983-91.
31. Fantry GT, Zheng QX, Darwin PE, Rosenstein AH, James SP. Mixed infection with cagA-positive and cagA-negative strains of Helicobacter pylori. Helicobacter 1996;1:98-106.
32. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, Perez-Perez GI, Blaser MJ. Serologie detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 1995;33:1496-500.
33. Atherton JC, Tham KT, Peek RM Jr, Cover TL, Blaser MJ. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis 1996;174:552-6.
34. Labenz J, Borsch G, Peitz U, Aygen S, Hennemann O, Tillenburg B, et al. Validity of a novel biopsy urease test (HUT) and a simplified 13C-urea breath test for diagnosis of H. pylori infection and estimation of the severity of gastritis. Digestion 1996:57:391-7.
35. 13C-urea breath rest to quantify H. pylori colonisation of gastric mucosa and association with severity of inflammation. Gastroenterology 1994;106:A48.
36. 13C-urea breath test. Gastroenterology 1994;106:A93.